This week President Trump signed a directive that will refocus America's space program on human exploration and discovery. Hanneke Weitering, Staff Writer at Space.com, joins Cheddar to discuss whether this decision means more funding from the White House for NASA. Weitering believes Trump's vision for what NASA can and should do is a little unclear at the moment, but says it won't impact private space exploration companies. She also talks about the Deep Space Gateway, which is supposed to be used as a "rest stop" on the way to the moon! Plus, she explains what research will be done in the next 5-10 years. NASA would like to look at different energy sources and explore more of the moon's surface.

Share:
More In Science
One Good Thing: All 14 Patients in Experimental Trial Saw Cancer Go Into Remission
What's being called an unprecedented breakthrough in cancer treatment recently completed a small trial at New York City's Memorial Sloan Kettering in 14 rectal cancer patients. The experimental trial with the drug dostarlimab resulted in 100 percent remission in all candidates, precluding the need for chemotherapy or surgery. Cheddar News anchor Hena Doba dives into this hopeful story.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More